110 related articles for article (PubMed ID: 16466277)
21. Pulmonary artery catheterization in exacerbations of COPD requiring mechanical ventilation: a cost-effectiveness analysis.
Smith KJ; Pesce RR
Respir Care; 1994 Oct; 39(10):961-7. PubMed ID: 10146114
[TBL] [Abstract][Full Text] [Related]
22. An economic evaluation of trauma care in a Canadian lead trauma hospital.
Séguin J; Garber BG; Coyle D; Hébert PC
J Trauma; 1999 Sep; 47(3 Suppl):S99-103. PubMed ID: 10496622
[TBL] [Abstract][Full Text] [Related]
23. Hospital costs of out-of-hospital cardiac arrest patients treated in intensive care; a single centre evaluation using the national tariff-based system.
Petrie J; Easton S; Naik V; Lockie C; Brett SJ; Stümpfle R
BMJ Open; 2015 Apr; 5(4):e005797. PubMed ID: 25838503
[TBL] [Abstract][Full Text] [Related]
24. A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom.
Bernard L; Mendelssohn D; Dunn E; Hutchison C; Grima DT
J Med Econ; 2013; 16(1):1-9. PubMed ID: 22857538
[TBL] [Abstract][Full Text] [Related]
25. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
[TBL] [Abstract][Full Text] [Related]
27. Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
Green C; Picot J; Loveman E; Takeda A; Kirby J; Clegg A
Pharmacoeconomics; 2005; 23(12):1271-82. PubMed ID: 16336020
[TBL] [Abstract][Full Text] [Related]
28. Clinical and economic effects of pulmonary artery catheterization in nonemergent coronary artery bypass graft surgery.
Ramsey SD; Saint S; Sullivan SD; Dey L; Kelley K; Bowdle A
J Cardiothorac Vasc Anesth; 2000 Apr; 14(2):113-8. PubMed ID: 10794325
[TBL] [Abstract][Full Text] [Related]
29. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.
Am J Respir Crit Care Med; 2002 Feb; 165(4):540-50. PubMed ID: 11850349
[TBL] [Abstract][Full Text] [Related]
30. Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs.
Grieve R; Cairns J; Thompson SG
Health Econ; 2010 Aug; 19(8):939-54. PubMed ID: 19688811
[TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
[TBL] [Abstract][Full Text] [Related]
32. An economic evaluation of prolonged mechanical ventilation.
Cox CE; Carson SS; Govert JA; Chelluri L; Sanders GD
Crit Care Med; 2007 Aug; 35(8):1918-27. PubMed ID: 17581479
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
34. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
[No Abstract] [Full Text] [Related]
35. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
Angus DC; Linde-Zwirble WT; Clermont G; Ball DE; Basson BR; Ely EW; Laterre PF; Vincent JL; Bernard G; van Hout B;
Crit Care Med; 2003 Jan; 31(1):1-11. PubMed ID: 12544986
[TBL] [Abstract][Full Text] [Related]
36. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).
Michaels JA; Campbell WB; Brazier JE; Macintyre JB; Palfreyman SJ; Ratcliffe J; Rigby K
Health Technol Assess; 2006 Apr; 10(13):1-196, iii-iv. PubMed ID: 16707070
[TBL] [Abstract][Full Text] [Related]
37. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
38. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M;
Diabet Med; 2007 Sep; 24(9):982-1002. PubMed ID: 17593245
[TBL] [Abstract][Full Text] [Related]
39. Quality, cost, and outcome of intensive care in a public hospital in Bombay, India.
Parikh CR; Karnad DR
Crit Care Med; 1999 Sep; 27(9):1754-9. PubMed ID: 10507594
[TBL] [Abstract][Full Text] [Related]
40. Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
Brennan A; Bansback N; Nixon R; Madan J; Harrison M; Watson K; Symmons D
Rheumatology (Oxford); 2007 Aug; 46(8):1345-54. PubMed ID: 17562686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
